1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. LABORATORY CORP. OF AMERICA HOLDINGS
Laboratory Corp. Of America Holdings
XNYS: LH
308.650.16(0.05%)
700.6K
XNYS Volume

XNYS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Labcorp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Labcorp share price target, revenues, EPS, net income and more

Labcorp quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Labcorp Jun-2026 Quarterly Revenue is $3,731 Million which is growth of 5.8% YoY.

  • POSITIVE

    Quarterly Net Profit Labcorp Jun-2026 Quarterly Net Profit is $299 Million which is growth of 25.6% YoY.

Laboratory Corp. Of America Holdings, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
3,731.13,537.63,515.83,563.53,527.33,345.13,329.43,2823,220.93,176.63,033.33,056.83,033.7
Cost Of Rev.
2,619.12,523.82,522.62,538.42,481.12,397.12,433.12,377.62,294.52,279.32,211.92,205.62,191.5
Gross Profit
1,1121,013.8993.21,025.11,046.2948896.3904.4926.4897.3821.4851.2842.2
⌄
655.3626.6611.2621.9647.6615.6665.6632.3620568.5592.1581.2557.3
Operating Profit
456.7387.2382403.2398.6332.4230.7272.1306.4328.8229.3270284.9
-61.1-55.1-55-56-57.1-56-63.4-50.4-47.6-46.9-48.8-50.3-49.8
Profit Before Tax
386.4319.7190.6337304.7275.2183.8210.6267.7297.4-147.1238.7205
Tax
87.341.725.775.566.462.240.24162.169.119.755.149.8
⌄
298.7277.8164.7261.1237.9212.8143.4169.3205.3228-167.1183.3188.9
Diluted NI Avail to Com Stockholders Ann.
298.7277.8164.7261.1237.9212.8143.4169.3205.3228-167.1183.3188.9
Basic EPS
3.73.423.12.92.51.722.42.7-22.12.1
Diluted EPS After ExtraOrdinary
3.63.33.13.22.92.51.52.32.52.70.92.11.9
Number Of Shares End
81.782.382.683.183.483.683.68484.184.184.786.688.7
Net Income Continuing Discontinued Operations
298.7277.8164.7261.1237.9212.8143.4169.3205.3228-167.1183.3188.9
Normalized Income
298.3272.8260.7263.5239.8212.7129190.6213.2229.577.3183.8165.7
Interest Income
-------------
Interest
61.155.1555657.15663.450.447.646.948.850.349.8
Net Interest Income
-61.1-55.1-55-56-57.1-56-63.4-50.4-47.6-46.9-48.8-50.3-49.8
EBIT
447.5374.8245.6393361.8331.2247.2261315.3344.3-98.3289254.8
EBITDA
626.5548.1418.6564532.1498417.8422.5472.2498.848.1434.9373.9
Reconciled Cost Of Rev.
2,518.22,426.12,422.22,436.92,379.12,299.92,332.92,279.82,199.82,184.92,124.72,115.42,123.9
Reconciled Depr.
179173.3173171170.3166.8170.6161.5156.9154.5146.4145.9119.1
Profit From Continuing Operations
299.1278164.9261.5238.3213143.6169.6205.6228.3-166.8183.6150.3
Normalized EBITDA
626542.3529.5567.1534.5497.9399.4449482.5500.8377.4435.5388
*All financials are in USD Million and price data in USD

Labcorp competitor comparison and performance snapshot within industry

Labcorp annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • POSITIVE

    Annual Revenue Labcorp Dec-2025 Annual Revenue is $13,952 Million which is growth of 7.2% YoY.

  • POSITIVE

    Annual Net Profit Labcorp Dec-2025 Annual Net Profit is $876 Million which is growth of 17.5% YoY.

Laboratory Corp. Of America Holdings, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-2.1%
0%
 13,951.713,008.912,161.614,876.816,120.913,978.511,554.811,333.410,441.49,641.88,680.1
Cost Of Rev. Ann.
-1.8%
1.9%
10,203.99,939.29,384.58,796.710,491.710,496.69,025.78,302.38,1576,977.46,461.35,776.8
Gross Profit Ann.
-2.9%
-4.1%
4,144.14,012.53,624.43,364.94,385.15,624.34,952.83,252.53,176.43,4643,180.52,903.3
Operating Exp. Ann.
3.4%
4.5%
2,5152,496.32,486.42,241.22,255.92,321.72,004.71,867.71,802.62,028.91,809.71,786.5
Operating Profit Ann.
-10.7%
-12.5%
1,629.11,516.21,1381,123.72,129.23,302.62,948.11,384.81,373.81,435.11,370.81,116.8
-
-
-227.2-224.1-208.3-199.6-180.3-212.1-207.4-240.7-244.2-235.1-219.1-274.9
Other Exp. Ann.
-
-
 -184.629.8-355.2-366.336.1-521.6-39.2138.7-65.1-46.2-109.8
PBT Ann.
-11.2%
-13%
1,233.71,107.5959.5568.91,582.63,126.62,219.11,104.91,268.31,134.91,105.5732.1
Tax Ann.
-8.7%
-19.1%
230.2229.8212.4188.5302747.1662.1280384.4-139.1372.3294.1
⌄
-11.8%
-10.8%
1,002.3876.57464181,279.12,377.31,556.1823.8883.71,268.2732.1436.9
Diluted NI Avail to Com Stockholders Ann.
-11.8%
-10.8%
1,002.3876.57464181,279.12,377.31,556.1823.8883.71,268.2732.1436.9
EPS Ann.
-9.4%
-8.1%
 10.58.94.814.124.6168.48.712.47.14.4
Diluted EPS Ann.
-9.1%
-8%
 10.58.84.81424.415.98.48.612.274.3
Number Of Shares End
-2.3%
-3.2%
 82.683.684.788.795.597.397.3100.2102.4103.1101.5
Total Exp. Ann.
-0.8%
2.4%
 12,435.511,870.911,037.912,747.612,818.311,030.410,1709,959.69,006.38,2717,563.3
Net Income Continuing Discontinued Operations Ann.
-11.8%
-10.8%
1,002.3876.57464181,279.12,377.31,556.1823.8883.71,268.2732.1436.9
Normalized Income Ann.
-14.7%
-12.6%
1,095.2968.7768.6626.31,559.72,402.31,901.88589121,309.5769.7504.1
Interest Income Ann.
-
-
 -----------
Interest Ann.
7.5%
1.6%
227.2224.1208.3199.6180.3212.1207.4240.7244.2235.1219.1274.9
EBITDA Ann.
-5.7%
-8%
2,157.22,012.71,811.31,345.82,396.84,083.83,051.21,922.82,064.61,903.21,823.81,464.8
Reconciled Cost Of Rev. Ann.
-1.9%
1.9%
9,803.49,538.18,997.48,439.210,117.110,121.18,676.47,968.37,836.66,660.76,141.65,483.5
Reconciled Depr. Ann.
2.4%
1.7%
696.3681.1643.5577.3633.9745.1624.7577.2552.1533.2499.2457.8
Profit From Continuing Operations Ann.
-11.8%
-10.8%
1,003.5877.7747.1380.41,280.62,379.51,557824.9883.91,274733.2438
Normalized EBITDA Ann.
-8.1%
-9.7%
2,264.92,1291,840.31,715.12,743.24,116.73,543.61,968.62,105.21,9721,880.51,576.8
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
7.2%
2Y CAGR
7.1%
3Y CAGR
-2.1%
5Y CAGR
0%
7Y CAGR
3%
10Y CAGR
4.9%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
17.5%
2Y CAGR
44.8%
3Y CAGR
-11.8%
5Y CAGR
-10.8%
7Y CAGR
-0.1%
10Y CAGR
7.2%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
0.4%
2Y CAGR
5.5%
3Y CAGR
3.4%
5Y CAGR
4.5%
7Y CAGR
4.8%
10Y CAGR
3.4%
Operating Expenses Annual Cr growth is lower than historical averages.

Labcorp balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Labcorp Dec-2025 Total Shareholders Fund is $8,620 Million which is growth of 7.0% YoY.

  • POSITIVE

    Total Assets Labcorp Dec-2025 Total Assets is $18,393 Million which is growth of 0.1% YoY.

Laboratory Corp. Of America Holdings, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-3%
-1.7%
18,392.718,37916,725.120,155.120,385.420,071.718,046.416,185.316,56814,24714,221.7
⌄
-1%
-1.8%
9,75610,312.58,834.610,039.610,091.410,691.310,459.39,194.89,717.28,7269,262.4
⌄
-5.1%
-1.6%
8,619.88,052.27,87510,096.610,273.49,359.77,5676,971.46,8305,505.84,944.4
Total Capitalization Ann.
-3.3%
-1.5%
13,704.413,383.411,929.715,135.415,689.914,778.713,356.812,962.313,116.810,742.410,881
Tangible Assets Ann.
-
-
-1,765.7-1,806.4-1,609.5-1,971.3-1,421-2,352.9-4,332.5-4,300-5,040.8-4,319.1-4,606.8
Working Capital Ann.
-8.2%
-10.2%
1,1971,476.3540.21,546.52,547.62,046.9325.4956.5636.5651.1961.5
Invested Capital Ann.
-2.7%
-1.3%
14,204.514,383.712,929.515,436.715,691.415,155.413,77212,972.313,52611,283.511,300.5
Tangible Book Value Ann.
-
-
-1,765.7-1,806.4-1,609.5-1,971.3-1,421-2,352.9-4,332.5-4,300-5,040.8-4,319.1-4,606.8
Borrowings Ann.
1.2%
-0.7%
6,5267,272.85,954.26,294.96,342.66,756.47,107.66,059.86,762.15,849.56,417
Net Debt Ann.
1%
2.5%
5,052.44,812.84,517.74,910.13,945.34,474.95,867.55,574.16,379.35,344.15,639.7
Share Issued Ann.
-2.3%
-3.4%
82.283.483.988.293.197.597.2122.4125.1125.6123.9
Number Of Shares End
-2.3%
-3.2%
82.683.684.788.795.597.397.3100.2102.4103.1101.5
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
0.1%
2Y CAGR
4.9%
3Y CAGR
-3%
5Y CAGR
-1.7%
7Y CAGR
1.8%
10Y CAGR
2.6%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
-15.2%
2Y CAGR
-6.4%
3Y CAGR
-2.8%
5Y CAGR
-1.7%
7Y CAGR
6%
10Y CAGR
5.2%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
7%
2Y CAGR
4.6%
3Y CAGR
-5.1%
5Y CAGR
-1.6%
7Y CAGR
3.1%
10Y CAGR
5.7%
Total ShareHolders Funds Annual growth is higher than historical averages.

Labcorp ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share Labcorp Book Value Per Share is $106 which is growth of 4.1% YoY.

  • NEUTRAL

    ROE Labcorp ROE is 0% which is growth of 0% YoY.

Laboratory Corp. Of America Holdings, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-4.25%2.27%6.31%11.75%8.16%4.81%5.40%8.23%5.14%4.06%
ROE Ann. %
-
-
-9.37%4.65%12.56%24.22%18.39%11.33%12.81%20.56%14.01%11.25%
ROIC %
-
-
-1.2-0.90.73.56.31.91.55.61.91.3
OPM Ann. %
-8.8%
-12.4%
10.87%8.75%9.24%14.31%20.49%21.09%11.98%12.12%13.74%14.22%12.87%
Inventory Turnover Ratio Ann.
-
-
-19.418.624.125.52734.535.132.232.635
Asset Turnover Ann. %
-
-
-0.70.70.70.80.70.70.70.70.70.8
Working Capital Turnover Ann.
6.8%
11.5%
11.78.822.59.66.36.835.511.916.414.89
Quick Ratio Ann.
-
-
-1.10.81.11.61.40.91.211.11.2
Current Ratio Ann.
-
-
-1.41.21.51.91.71.11.51.31.41.6
Interest Coverage Ratio Ann.
-
-
-5.63.99.815.711.75.66.25.86.13.7
LT Debt To Equity Ann.
-
-
-0.80.60.60.60.70.90.90.911.2
*All financials are in USD Million and price data in USD

Labcorp cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • POSITIVE

    Cash From Operating Activity Labcorp Dec-2025 Cash From Operating Activity is $1,640 Million which is growth of 3.4% YoY.

  • NEGATIVE

    Net Cash Flow Labcorp Dec-2025 Net Cash Flow is $-1,010 Million which is growth of -201.2% YoY.

Laboratory Corp. Of America Holdings, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-5.7%
-5.1%
1,640.51,585.81,202.31,955.93,109.62,135.31,444.71,305.41,459.41,175.9982.4
-
-
-1,194-1,366.8-1,146.8-1,652.2-884.6-643.2-1,283.1206.7-2,228.7-795.7-3,994.9
-
-
-1,457779.9-1,559-1,322.2-2,065.8-517.4-252.7-1,389.9631.9-649.83,184.6
Cash Plus Cash Eqv. End Of Year Ann.
7.4%
-16.6%
532.31,518.7536.84301,472.71,320.8337.5426.8316.7433.6716.4
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-1,010.5998.996.9-1,018.5159.2974.7-91.1122.2-137.4-269.6172.1
Cash Plus Cash Eqv. Begin Of Year Ann.
1%
35.1%
1,518.7536.84301,472.71,320.8337.5426.8316.6433.6716.4580
Income Tax Paid Supplemental Data Ann.
-30.3%
-
171.1215.4206.8504.7---349.7348345.7249.4
Interest Paid Supplemental Data Ann.
3.4%
-
217.7209.2221.5197.1---296.2239.1210.7166.1
Capex Ann.
-
-
-434.5-489.9-453.6-481.9-460.4-381.7-400.2-379.8-315.4-278.9-255.8
Issuance Of Capital Stock Ann.
-
-
--54.450.651.755.964.769.173.670.698.9
Issuance Of Debt Ann.
-56.5%
-15.6%
64.84,463.72,488.2787.41,000151.72,395467.23,342.2139.54,360
Repayment Of Debt Ann.
-
-
-1,064.8-3,463.7-2,788.2-787.4-1,375-563.9-2,184.9-1,171.8-2,426.9-806.3-1,250.6
Repurchase Of Capital Stock Ann.
-
-
-450-250.1-1,000-1,100-1,668.5-100-450-700-338.1-43.9
Free Cash Flow Ann.
-6.5%
-7.2%
1,2061,095.9874.11,4742,649.21,753.61,044.5925.61,144897726.6
*All financials are in USD Million and price data in USD
Cash from Operating Act. Ann.
1Y CHG
3.4%
2Y CAGR
16.8%
3Y CAGR
-5.7%
5Y CAGR
-5.1%
7Y CAGR
3.3%
10Y CAGR
5.3%
Cash from Operating Activity Annual growth is higher than historical averages.